• Follow the Money: Investments for Underserved Lung Cancer Communities

    Aug 05 | Clinical Research News | Stand Up To Cancer gets a big pharma investment aimed at achieving health equity for underserved lung cancer patients, including Black people and people living in rural communities. And Sema4 gets $121M to build dynamic models of human health and define optimal, individualized health trajectories. More
  • Are Our COVID-19 Trials Useful, Ethical? Researcher Raise Red Flags

    Jul 31 | Clinical Research News | Groups of researchers are raising red flags about the quality of COVID-19 clinical trials. A group from Stanford and Yale warned that studies may not be well designed to contribute meaningful clinical evidence. Another group from Johns Hopkins cautioned against overstepping ethical bounds in public health surveillance. Meanwhile, many new trials are launched.  More
  • John Snow Labs, LabCorp, FDA, And More: News From July 2020

    Jul 30 | Clinical Research News | July was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from John Snow Labs, LabCorp, the FDA, and more. More
  • Pandemic Inspires Impactful Public-Private Partnerships

    Jul 28 | Clinical Research News | If COVID-19 has an upside, it’s that the public health crisis has turned fierce competitors unto friendly collaborators and forged unlikely partnerships between groups who tackle problems from a different angle. More
  • How St. Jude Research Hospital’s New SVP of Clinical Trials Administration is Weathering the Pandemic

    Jul 27 | Clinical Research News | While the short-term impacts of the COVID-19 pandemic have certainly slowed clinical research, St. Jude’s new Senior Vice President of Clinical Trials Administration keeps a long view, with some initial goals—including an expanded clinical infrastructure and informatics—becoming more important than ever. More
  • NIAID Establishes COVID-19 Prevention Network, Other News

    Jul 24 | Clinical Research News | The NIAID recently established the COVID-19 Prevention Network with the goal to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19. This, plus more, is included in this week’s announcements and updates from the clinical research industry. More
  • Accelerating Toward a New Era of Clinical Research

    Jul 23 | Clinical Research News Contributed Commentary | The modern clinical trial will reduce the patient burden, increase speed of execution, and improve collaboration across stakeholders. More
  • Anthony Fauci: Pandemic Potential of Coronaviruses Nothing New

    Jul 21 | Clinical Research News | In his opening keynote address at the American Association for Cancer Research virtual meeting on COVID-19 and cancer yesterday, Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, stayed true to his reputation as a beacon of knowledge and truth in the battle against a confounding viral foe. More
  • 2000 Volunteers Urge NIH to Begin Human Challenge Trials For COVID-19

    Jul 17 | Clinical Research NewsMore than 100 researchers, clinicians, and Nobel Laureates signed a letter sent to Francis Collins, director of the National Institutes of Health, yesterday emphasizing the “vast importance of human challenge trials” in developing a vaccine for COVID-19. More
  • Evaluating the Efficacy of COVID-19 Vaccines in Production, Other News

    Jul 16 | Clinical Research News | Researchers outline the challenges in evaluating the efficacy of the COVID-19 vaccines that are in production. This, plus more, are included in this week’s announcements and updates from the clinical research industry. More
View more articles
The DIA 2020 Global Annual Meeting is more than a meeting: it's an experience focused on the future of health. Spanning the life sciences spectrum, DIA 2020 will compile more than 250 sessions over 13 unique tracks with nine various learning formats, ensuring each attendee has the best learning opportunities.

Affiliated Reports Collection
Patient-centric pharma - Advancing the new business model  reveals how success can be achieved and provides food for thought on various ways to place patients firmly at the heart of your business and achieve commercially beneficial outcomes.